Home/Pipeline/OcuLenz

OcuLenz

Central Vision Loss

CommercialActive

Key Facts

Indication
Central Vision Loss
Phase
Commercial
Status
Active
Company

About Ocutrx Technologies

Ocutrx Technologies is a private, pre-revenue medical device innovator leveraging AR/XR technology to address unmet needs in ophthalmology, specifically central vision loss. The company's initial product, OcuLenz, is a head-worn low vision aid that aims to help patients with conditions like macular degeneration read, recognize faces, and watch TV by digitally enhancing their remaining peripheral vision. While the device is FDA-registered, it is not yet cleared for Age-Related Macular Degeneration (AMD), indicating a targeted initial market and a clear regulatory pathway for future expansion. The company's leadership includes seasoned executives from the tech and business sectors, positioning it to navigate the complex intersection of medical devices and immersive digital technology.

View full company profile

Therapeutic Areas